Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06984705 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 29, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Secondary endpoints: details revised at 1 of 1 entryv2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to evaluate the effectiveness of smallpox vaccination administered before the global eradication of smallpox against currently circulating mpox in the Democratic Republic of the Congo. The main question it aims to answer is: Is the smallpox vaccine experience protective against mpox infection ? Researchers will compare mpox test positive group and negative group to see if the smallpox vaccine can protect against mpox infection. Participants will * be included after informed consent, * respond the survey with structured questionnaire * and accept skin lesion and blood sampling.
Trial Details
NCT Number NCT06984705
Lead Sponsor Osaka Metropolitan University
Collaborators: Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Conditions
(from sponsor)
Mpox (Monkeypox)
Related terms Mpox, Monkeypox
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov